J&J vaccine adds to COVID-19 armoury, includes South African variant

January 29, 2021

By Julie Steenhuysen

(Reuters) – Johnson & Johnson said on Friday that its single-dose vaccine was 66% effective in preventing COVID-19 in a large global trial against multiple variants, giving health officials another weapon to tackle the pandemic.

In the trial of nearly 44,000 volunteers, the [READ MORE]

The Daily Digest

Aggregated and original content that you can trust

J&J vaccine adds to COVID-19 armoury, includes South African variant

Follow this blog